Applicants,Chemical_Name,Funding_requested_for,Pharmaceutical,Priority_List,Schedules,Therapeutic_group
Clinician,Ustekinumab,"Psoriasis, chronic plaque, 2nd line",Ustekinumab,Options for investment,Community and Hospital,
